Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability
Alfiya Distler(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jörg H. W. Distler(Düsseldorf University Hospital), Oliver Distler(University Hospital of Zurich), Katrin Palumbo‐Zerr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Veronika Lang(Friedrich-Alexander-Universität Erlangen-Nürnberg), Georg Schett(Karolinska University Hospital), Neng‐Yu Lin(National Taiwan University), Yun Zhang(Shenzhen Maternity and Child Healthcare Hospital), Jingang Huang(Hangzhou Dianzi University), Christian Beyer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Tina Del Vecchio(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 36
Related Papers
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
|Nature Communications|2012|824
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
EULAR definition of difficult-to-treat rheumatoid arthritis
|Annals of the Rheumatic Diseases|2020|538